No Data
SPDR S&P Biotech ETF Options Spot-On: On May 22nd, 103.82K Contracts Were Traded, With 1.12 Million Open Interest
On May 22nd ET, $SPDR S&P Biotech ETF(XBI.US)$ had active options trading, with a total trading volume of 103.82K options for the day, of which put options accounted for 68.91% of the total transactio
SPDR S&P Biotech ETF Options Spot-On: On May 17th, 98,268 Contracts Were Traded, With 1.38 Million Open Interest
On May 17th ET, $SPDR S&P Biotech ETF(XBI.US)$ had active options trading, with a total trading volume of 98,268 options for the day, of which put options accounted for 61.29% of the total transaction
SPDR S&P Biotech ETF Options Spot-On: On May 15th, 117.13K Contracts Were Traded, With 1.32 Million Open Interest
On May 15th ET, $SPDR S&P Biotech ETF(XBI.US)$ had active options trading, with a total trading volume of 117.13K options for the day, of which put options accounted for 55.38% of the total transactio
Health Care Is Still Very Crowded but Trades at a Discount Vs. History - BofA
The health care sector (NYSEARCA:XLV) is crowded despite a reversal on the recession outlook, according to BofA Securities’ Sector Focus Point report.
Top ETFs With the Most and Least Options Activity - Barclays
Editas Medicine Upgraded at J.P. Morgan on Recent Weakness